Spirecut establishes presence in the Basel Area
Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. The company is now operating out of “The 5th Floor” co-working space in Muttenz. The startup has relocated with the help of the “100 fürs Baselbiet” program operated by BLKB and with the support of Basel Area Business & Innovation.
Frédéric Schuind, CEO and founder of Spirecut (img: Spirecut)
Spirecut AG is now based in Muttenz in the canton of Basel-Landschaft. The medtech startup, which was headquartered in Fribourg up until the end of March, develops and sells instruments for two surgical fields of hand operations: carpal tunnel syndrome and trigger finger. In each case, the instruments facilitate minimally invasive procedures in which no incision is necessary. Rather, the surgeon merely has to puncture the skin.
As a result, in contrast to conventional operations, patients can immediately use their hand as normal again. Spirecut was awarded third place in the 2022 Swiss Innovation Challenge.
Founded in 2020, the company was supported in establishing its presence in the Basel Area by the “100 fürs Baselbiet” promotional program operated by BLKB, the cantonal bank for the canton of Basel-Landschaft, further details of which can be found in a statement. The aim of the initiative is to bring 100 companies to the canton of Basel-Landschaft, with debt capital of up to 500,000 Swiss francs available to finance the next growth step. The bank also offers coaching and mentoring in all relevant areas via its partners.
Unique ecosystem for medtech firms
The investment and innovation promotion agency Basel Area Business & Innovation functioned as a relocation partner and aided the search for suitable premises, which were eventually found at The 5th Floor coworking space in Muttenz. In the words of the Swiss-Belgian founder and CEO of Spirecut, Professor Frédéric Schuind, his company opted for the Basel region due to the fact that “it offers a unique ecosystem for medtech firms that encourages innovation and collaboration in a supportive environment”.
The medtech firm is keen to get in touch with the leading players in the Basel Area to sound out cooperation opportunities, informs Spirecut. The proximity to the University of Applied Sciences and Arts Northwestern Switzerland (FHNW), as well as the University of Basel, University Hospital Basel and the Basel Area life sciences ecosystem and its suppliers, will open up recruitment opportunities for the company.
You may also be interested in
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...Read More
University of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...Read More
Rami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...Read More
Basel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....Read More
Roche and Novartis among global leaders for research spending
In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...Read More
Roche to found Institute for Human Biology
Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...Read More